Frankfurt - Delayed Quote EUR

Athens Medical C.S.A. (ACS.F)

1.4400 -0.1100 (-7.10%)
At close: May 31 at 8:07 AM GMT+2
Loading Chart for ACS.F
DELL
  • Previous Close 1.5500
  • Open 1.4400
  • Bid 1.4250 x --
  • Ask 1.7600 x --
  • Day's Range 1.4400 - 1.4400
  • 52 Week Range 1.4200 - 2.0800
  • Volume 17
  • Avg. Volume 18
  • Market Cap (intraday) 128.123M
  • Beta (5Y Monthly) 1.15
  • PE Ratio (TTM) 16.00
  • EPS (TTM) 0.0900
  • Earnings Date Apr 30, 2024
  • Forward Dividend & Yield 0.03 (1.94%)
  • Ex-Dividend Date Sep 7, 2023
  • 1y Target Est --

Athens Medical C.S.A., together with its subsidiaries, offers healthcare services in Greece and internationally. The company offers diagnosis and treatment for prostate bladder, kidney, and testicular cancer, as well as interventional cardiology, interventional electrophysiology, and pediatric cardiology; cardiac surgery; robotic surgery, including general, gynecologic, and urology services; and neuro- and spine surgery services. It also provides medical services for range of orthopedics, such as foot and ankle, hand and wrist, hip, knee, shoulder, and spine; sports injuries; plastic Surgeries for face, body, breast, obesity, reconstructive plastic surgery, scar correction, and sex reassignment; bariatric surgery for gastric banding, sleeve gastrectomy, and biliopancreatic diversion with duodenal switch; and chronic diseases, including diabetes, endocrinology, heat failure, high blood pressure, pain management, respiratory system, stroke, and thyroid conditions. In addition, the company operates wellness and prevention centers; and offers medical education, training, and practice services. The company was founded in 1983 and is based in Athens, Greece.

www.iatriko.gr

3,230

Full Time Employees

December 31

Fiscal Year Ends

Recent News: ACS.F

Performance Overview: ACS.F

Trailing total returns as of 5/31/2024, which may include dividends or other distributions. Benchmark is

.

YTD Return

ACS.F
11.38%
COMPOSITE INDEX
10.73%

1-Year Return

ACS.F
0.54%
COMPOSITE INDEX
16.88%

3-Year Return

ACS.F
199.78%
COMPOSITE INDEX
61.32%

5-Year Return

ACS.F
199.78%
COMPOSITE INDEX
74.97%

Compare To: ACS.F

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: ACS.F

Valuation Measures

Annual
As of 5/30/2024
  • Market Cap

    137.91M

  • Enterprise Value

    274.46M

  • Trailing P/E

    16.63

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    0.52

  • Price/Book (mrq)

    1.24

  • Enterprise Value/Revenue

    1.06

  • Enterprise Value/EBITDA

    7.18

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    3.64%

  • Return on Assets (ttm)

    3.48%

  • Return on Equity (ttm)

    8.68%

  • Revenue (ttm)

    249.37M

  • Net Income Avi to Common (ttm)

    9.07M

  • Diluted EPS (ttm)

    0.0900

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    16.34M

  • Total Debt/Equity (mrq)

    138.51%

  • Levered Free Cash Flow (ttm)

    -29.42M

Research Analysis: ACS.F

Company Insights: ACS.F

Research Reports: ACS.F